TOI - Oncology Institute Inc (The)
IEX Last Trade
0.3612
-0.020 -5.648%
Share volume: 123,037
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
PREVIOUS CLOSE
CHG
CHG%
$0.38
-0.02
-5.35%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
Report Date | 2022-05-10 | 2022-08-09 | 2022-11-09 | 2023-03-16 | 2023-05-10 | 2023-08-09 | 2023-11-08 | 2024-03-28 | |
Assets | |||||||||
Total Assets | 206.512 M | 189.740 M | 283.802 M | 261.665 M | 234.633 M | 229.959 M | 218.353 M | 209.240 M | |
Current Assets | 139.840 M | 112.205 M | 143.631 M | 130.418 M | 118.962 M | 104.071 M | 152.682 M | 143.493 M | |
Inventories | 7.770 M | 8.580 M | 10.018 M | 9.261 M | 10.254 M | 12.168 M | 12.174 M | 13.678 M | |
Other Current Assets | 10.744 M | 10.048 M | 7.655 M | 6.918 M | 6.942 M | 5.827 M | 4.190 M | 4.049 M | |
Short Term Investments | 10.744 M | 10.048 M | 7.655 M | 6.918 M | 6.942 M | 5.827 M | 4.190 M | 4.049 M | |
Total Receivables | 25.792 M | 29.369 M | 35.379 M | 40.433 M | 46.384 M | 46.893 M | 48.906 M | 42.911 M | |
Current Cash | 95.534 M | 64.208 M | 90.579 M | 73.806 M | 55.382 M | 39.183 M | 87.412 M | 82.855 M | |
Total Non-current Assets | 66.672 M | 77.535 M | 140.171 M | 131.247 M | 115.671 M | 125.888 M | 65.671 M | 65.747 M | |
Property Plant Equipment | 4.909 M | 6.014 M | 7.006 M | 8.547 M | 9.846 M | 10.772 M | 10.787 M | 10.883 M | |
Other Assets | 17.565 M | 17.662 M | 25.269 M | 24.971 M | 25.205 M | 29.598 M | 29.093 M | 29.730 M | |
Intangible Assets | 17.572 M | 19.383 M | 18.665 M | 17.957 M | 17.228 M | 19.344 M | 18.561 M | 17.904 M | |
Goodwill | 26.626 M | 34.476 M | 31.016 M | 21.418 M | 4.551 M | 7.230 M | 7.230 M | 7.230 M | |
Liabilities and shareholders’ equity | |||||||||
Total Liabilities and shareholders’ equity | 206.512 M | 189.740 M | 283.802 M | 261.665 M | 234.633 M | 229.959 M | 218.353 M | 209.240 M | |
Total liabilities | 74.514 M | 65.757 M | 155.868 M | 138.490 M | 136.227 M | 145.237 M | 146.504 M | 152.215 M | |
Total current liabilities | 31.521 M | 36.128 M | 32.852 M | 29.720 M | 30.085 M | 33.506 M | 32.390 M | 34.788 M | |
Accounts Payable | 12.596 M | 13.900 M | 11.155 M | 9.372 M | 11.946 M | 13.123 M | 13.333 M | 14.429 M | |
Other liabilities | 28.033 M | 14.513 M | 21.565 M | 5.981 M | 1.665 M | 1.318 M | 2.688 M | 4.083 M | |
Current long term debt | 4.277 M | 4.486 M | 5.163 M | 5.498 M | 5.639 M | 6.001 M | 6.079 M | 6.363 M | |
Long term debt | 14.409 M | 14.614 M | 100.897 M | 102.681 M | 104.395 M | 110.335 M | 111.268 M | 113.312 M | |
Other liabilities | 28.033 M | 14.513 M | 21.565 M | 5.981 M | 1.665 M | 1.318 M | 2.688 M | 4.083 M | |
Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Total Shareholder equity | 131.998 M | 123.983 M | 127.934 M | 123.175 M | 98.406 M | 84.722 M | 71.849 M | 57.025 M | |
Common stock | 73.252 M | 72.997 M | 72.184 M | 72.740 M | 73.449 M | 74.120 M | 73.469 M | 73.956 M | |
Retained earnings | -43.948 M | -49.401 M | -52.075 M | -63.082 M | -93.080 M | -109.977 M | -127.396 M | -146.150 M |